SAN
FRANCISCO, Feb. 14, 2023 /PRNewswire/ -- Invitae
(NYSE: NVTA), a leading medical genetics company, today announced
that it will report its fourth quarter and full year 2022 financial
results on Tuesday, February 28,
2023, and will host a conference call and webcast that day
at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial
results and recent highlights.
To access the conference call, please register at the link
below:
https://www.netroadshow.com/events/login?show=d75171b5&confId=46549
Upon registering, each participant will be provided with call
details and access codes.
The live webcast of the call and slide deck may be accessed
here or by visiting the investors section of the
company's website at ir.invitae.com. A replay of the webcast will
be available shortly after the conclusion of the call and will be
archived on the company's website.
About Invitae
Invitae Corporation (NYSE: NVTA) is a leading medical
genetics company whose mission is to bring comprehensive genetic
information into mainstream medicine to improve healthcare for
billions of people. Invitae's goal is to aggregate the world's
genetic tests into a single service with higher quality, faster
turnaround time, and lower prices. For more information, visit the
company's website at invitae.com.
Contact:
Hoki Luk
ir@invitae.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/invitae-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-28-2023-301745488.html
SOURCE Invitae Corporation